Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.715 AUD | +1.42% | +0.70% | -20.56% |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoid-based Medicines
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -80.45% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
70.9
%
| 1 | 95.7 % | 0 | 70.9 % | -85.51% |
Australia
29.1
%
| 0 | 4.3 % | 0 | 29.1 % | +31.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oludare Odumosu
CEO | Chief Executive Officer | - | 27/11/19 |
Rahul Ganesan
DFI | Director of Finance/CFO | - | - |
Greg Blake
BRD | Director/Board Member | - | 31/12/19 |
Timothy Slate
BRD | Director/Board Member | - | 19/10/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Osagie Imasogie
CHM | Chairman | 62 | 27/11/19 |
Timothy Slate
BRD | Director/Board Member | - | 19/10/16 |
Oludare Odumosu
CEO | Chief Executive Officer | - | 27/11/19 |
Greg Blake
BRD | Director/Board Member | - | 31/12/19 |
Donna O’Donnell
BRD | Director/Board Member | - | 31/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,347,155 | 5,820,324 ( 51.29 %) | 0 | 51.29 % |
Company contact information
Zelira Therapeutics Ltd.
101 St George’s Terrace Level 3
6000, Perth
+61 8 6558 0886
http://zeliratx.comSector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.56% | 5.22M | |
-2.65% | 103B | |
+1.75% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.47% | 16.05B | |
+5.43% | 13.68B | |
+34.20% | 12.17B |
- Stock Market
- Equities
- ZLD Stock
- Company Zelira Therapeutics Limited